Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q1 2026 · 10-Q
Revenue$39.48M$39.48M+4.2% vs Q1 2025 Net Income-$3.79M-$3.79MN/M vs Q1 2025 EPS Diluted-$0.01-$0.01N/M vs Q1 2025 Gross Profit$15,276,000+1.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flow$949,000−26.6% Free Cash Flowderived$576,000−43.9% Margins · derivedGross margin38.7%−1.1 pt vs Q1 2025
Operating margin0.3%+2.7 pt vs Q1 2025
Net margin-9.6%+5.0 pt vs Q1 2025
ended Mar 31, 2026 · filed May 14, 2026 · 44 d after period end